Fig. 2.
Fig. 2. Cytokine-mediated priming of neutrophil NADPH oxidase activity in patients in steady-state (A and B) or crisis (C and D) of SCD compared with controls tested on the same day. Whole-blood samples were incubated with either rhTNF-α (A and C), rhGM-CSF (B and D), at the doses indicated, or FCS diluent for 30 minutes at 37°C, followed by stimulation for 15 minutes with 1 μmol/L FMLP or PBS. Neutrophil H2O2 production was measured by the oxidation of dichlorodihydrofluorescein (DCF) using flow cytometry, as described in Materials and Methods. Total H2O2 production was calculated as the product of the percent of positive cells and their standardized MCF. The data shown are the mean ± 1 SE of (A) 10 experiments, (B) 7 experiments, and (C and D) six experiments. Significant differences between patients and controls (Wilcoxon's matched pairs signed-ranks test) are shown: *P < .01, †P < .005. (-•-), Patient + FMLP; (-○-), control + FMLP; (-▪-), patient + PBS; (-□-), control + PBS.

Cytokine-mediated priming of neutrophil NADPH oxidase activity in patients in steady-state (A and B) or crisis (C and D) of SCD compared with controls tested on the same day. Whole-blood samples were incubated with either rhTNF-α (A and C), rhGM-CSF (B and D), at the doses indicated, or FCS diluent for 30 minutes at 37°C, followed by stimulation for 15 minutes with 1 μmol/L FMLP or PBS. Neutrophil H2O2 production was measured by the oxidation of dichlorodihydrofluorescein (DCF) using flow cytometry, as described in Materials and Methods. Total H2O2 production was calculated as the product of the percent of positive cells and their standardized MCF. The data shown are the mean ± 1 SE of (A) 10 experiments, (B) 7 experiments, and (C and D) six experiments. Significant differences between patients and controls (Wilcoxon's matched pairs signed-ranks test) are shown: *P < .01, †P < .005. (-•-), Patient + FMLP; (-○-), control + FMLP; (-▪-), patient + PBS; (-□-), control + PBS.

Close Modal

or Create an Account

Close Modal
Close Modal